A Republican push to repeal and replace Obamacare has slowed amid concerns over large numbers of people losing health coverage. » Read More
By: Trent Gillies
Former Aetna CEO Ron Williams weighs in on what changes could be ahead for the Affordable Care Act and consumers. » Read More
By: Dan Mangan
UnitedHealth denies allegations it gamed the nation's Medicare system for hundreds of millions of dollars. » Read More
By: Bertha Coombs
House Speaker Paul Ryan said they plan to introduce legislation as early as next Tuesday. » Read More
Molina blamed Obamacare for a fourth-quarter loss and 2017 profit forecast far below estimates.
Obamacare repeal and failed insurance mergers have been dominating health-care headlines, but some surprise stock winners may emerge.
Spending on health nationally grew by an estimated 4.8 percent in 2016, but is expected to rise at a quicker pace through 2025.
This is occurring even as the Trump administration issues new rules to try to stabilize the Obamacare exchanges.
Tax filers remain responsible for paying a penalty if they fail to have health insurance coverage or an exemption from that mandate.
Open enrollment would run from November through Dec. 15, and states would have control over the size of an insurance plan's network.
Sen. John Barrasso (R-Wyoming) discusses the Congressional push to repeal and replace the Affordable Care Act.
In the wake of Humana's comment, President Donald Trump tweeted that the insurer's decision was another example of Obamacare's failure.
Just 8.8 percent of Americans lack health coverage as Republicans move to repeal key parts of the Affordable Care Act.
Humana, Aetna, Credit Suisse, and Popeyes stocks are making headlines this Valentine's day.
Health insurer Aetna and rival Humana say they have mutually ended their $34 billion merger agreement.
Aetna and Humana announce that their proposed merger agreement has been mutually terminated.
The key to boosting Japan’s sluggish economy isn’t more monetary policy, it’s making households feel secure, a former BOJ board member said.
Marathon says it will charge $89,000 for its Duchenne muscular dystrophy treatment, despite it having sold elsewhere for just $1,000.
Insurers could end up being owed almost $15 billion in payments from the government under an Obamacare risk-mitigation program.
Health officials also recently gutted much of outreach designed to spur sign-ups on the the federal Obamacare exchanges.
Get the best of CNBC in your inbox